The Health Care Select Sector SPDR (NYSEArca: XLV) ranks as the second-best SPDR in June.
Despite prior weakness induced by the biotechnology sell-off, XLV has regained much of that lost ground, entering Friday’s session just 1.1% below its 52-week high and higher by nearly 3% over the past month. [Leveraged Health Care ETF Attracts Buyers]
For as strong as the health care sector has been in recent years, XLV has tripled since the March 2009 market bottom, the ETF only ranks as one of the two best SPDRs on a monthly basis in one other month, according to CXO. That month is January, in which XLV is usually the best of the nine SPDRs.
Health Care Select Sector SPDR
